Pharmaceutical Industry News
Ambu to launch US FDA approved sterile, single-use duodenoscope, aScope Duodeno
The Ambu, a company develop, produce and market diagnostic and life-supporting devices for hospitals and rescue services, announced that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for aScope Duodeno on 17 July 2020 and is now ready for commercial launch as planned
Engineering | 20/07/2020 | By Darshana
Wipro 3D collaborates with SCTIMST launches emergency breathing assist system, AirBridge
Wipro 3D, a business of Wipro Infrastructure Engineering, in technical collaboration with Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), Thrivuvananthapuram, has launched AirBridge, the Wipro Chitra Emergency Breathing Assist System (EBAS)
Engineering | 08/07/2020 | By Darshana
FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer
Today, the U.S. Food and Drug Administration approved Keytruda (pembrolizumab) for intravenous injection for the first-line treatment of patients with unresectable or metastatic microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) colorectal cancer
Engineering | 01/07/2020 | By Darshana
FDA Approves New Therapy for Dravet Syndrome
The U.S. Food and Drug Administration today approved Fintepla (fenfluramine), a Schedule IV controlled substance, for the treatment of seizures associated with Dravet syndrome in patients age 2 and older. Dravet syndrome is a life-threatening, rare and chronic form of epilepsy. It is often characterized by severe and unrelenting seizures
Engineering | 29/06/2020 | By Darshana
today announced the CE-IVD launch of its automated digital pathology algorithm, the uPath PD-L1 (SP263) image analysis for non-small cell lung cancer (NSCLC). The algorithm provides pathologists with automated assessments of scanned slide images that are objective and reproducible and have the potential to aid diagnosis
Engineering | 26/06/2020 | By Darshana
Cipla launches generic remdesivir for COVID-19
Cipla Limited announced the launch of generic version of remdesivir under its brand name Cipremi. The US FDA issued an emergency use authorization (EUA) to Gilead Sciences Inc. for emergency use of remdesivir for the treatment of hospitalized 2019 coronavirus disease (COVID-19) patients
Engineering | 22/06/2020 | By Darshana
Glenmark Pharma launches favipiravir drug for COVID-19 treatment
Glenmark Pharmaceuticals, a research-led, integrated global pharmaceutical company, has launched antiviral drug favipiravir (brand name FabiFlu) for the treatment of mild to moderate COVID-19 patients
Engineering | 22/06/2020 | By Darshana
On the lines of the medical apps being used by healthcare professionals and chronic patients to avail information on medicines and doctors? services, the pharmaceutical manufacturing companies worldwide have started launching Pharma Apps to educate doctors and hospital administrators about new drugs
Engineering | 16/06/2020 | By Darshana
The COVID19 pandemic has so far affected 216 countries and caused more than 59.31 lakh cases and 3.65 lakh deaths worldwide
Engineering | 02/06/2020 | By Darshana
FDA Takes New Actions to Accelerate Development of Novel Prevention, Treatment Options for COVID-19
Today, the U.S. Food and Drug Administration took important actions to help accelerate the development of prevention and treatment options for COVID-19 by providing new guidance with recommendations for innovators and researchers conducting work in this area
Engineering | 12/05/2020 | By Darshana
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy